Marye J. Boers‐Sonderen

Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma

Maartje W. Rohaan, Troels Holz Borch, Joost H. van den Berg et al. · New England Journal of Medicine · 2022 · 536 citations · Full text

Medicine, Immunology, Oncology +17

Five-Year Analysis of Adjuvant Pembrolizumab or Placebo in Stage III Melanoma

Alexander M.M. Eggermont, Michal Kiciński, Christian U. Blank et al. · NEJM Evidence · 2022 · 150 citations

Pharmacy, Oncology, Pharmacotherapy +17

Association of Immune-Related Adverse Event Management With Survival in Patients With Advanced Melanoma

Olivier J. van Not, Rik J. Verheijden, Alfonsus Johannes Maria van den Eertwegh et al. · JAMA Oncology · 2022 · 106 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Safety and Efficacy of Checkpoint Inhibition in Patients With Melanoma and Preexisting Autoimmune Disease

Monique K. van der Kooij, Karijn P.M. Suijkerbuijk, Maureen J.B. Aarts et al. · Annals of Internal Medicine · 2021 · 105 citations · Full text

Life Sciences, Immunology, Oncology +17

Phase 2 Study of Lutetium 177–Labeled Anti–Carbonic Anhydrase IX Monoclonal Antibody Girentuximab in Patients with Advanced Renal Cell Carcinoma

Marye J. Boers‐Sonderen, Tim J. van Oostenbrugge, Otto C. Boerman et al. · European Urology · 2015 · 104 citations

Medicine, Oncology, Pharmacology +15